GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » PreveCeutical Medical Inc (XCNQ:PREV) » Definitions » ROA %

PreveCeutical Medical (XCNQ:PREV) ROA % : -482.41% (As of Sep. 2023)


View and export this data going back to 2016. Start your Free Trial

What is PreveCeutical Medical ROA %?

ROA % is calculated as Net Income divided by its average Total Assets over a certain period of time. PreveCeutical Medical's annualized Net Income for the quarter that ended in Sep. 2023 was C$-0.96 Mil. PreveCeutical Medical's average Total Assets over the quarter that ended in Sep. 2023 was C$0.20 Mil. Therefore, PreveCeutical Medical's annualized ROA % for the quarter that ended in Sep. 2023 was -482.41%.

The historical rank and industry rank for PreveCeutical Medical's ROA % or its related term are showing as below:

XCNQ:PREV' s ROA % Range Over the Past 10 Years
Min: -846.29   Med: -529.56   Max: 51.18
Current: 51.18

During the past 8 years, PreveCeutical Medical's highest ROA % was 51.18%. The lowest was -846.29%. And the median was -529.56%.

XCNQ:PREV's ROA % is ranked better than
99.42% of 1552 companies
in the Biotechnology industry
Industry Median: -34.765 vs XCNQ:PREV: 51.18

PreveCeutical Medical ROA % Historical Data

The historical data trend for PreveCeutical Medical's ROA % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

PreveCeutical Medical ROA % Chart

PreveCeutical Medical Annual Data
Trend Jul15 Jul16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
ROA %
Get a 7-Day Free Trial -527.94 -259.35 -655.34 -746.00 -846.29

PreveCeutical Medical Quarterly Data
Jun18 Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Sep23
ROA % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -1,526.35 -1,134.69 -2,178.84 781.29 -482.41

Competitive Comparison of PreveCeutical Medical's ROA %

For the Biotechnology subindustry, PreveCeutical Medical's ROA %, along with its competitors' market caps and ROA % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


PreveCeutical Medical's ROA % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, PreveCeutical Medical's ROA % distribution charts can be found below:

* The bar in red indicates where PreveCeutical Medical's ROA % falls into.



PreveCeutical Medical ROA % Calculation

PreveCeutical Medical's annualized ROA % for the fiscal year that ended in Dec. 2022 is calculated as:

ROA %=Net Income (A: Dec. 2022 )/( (Total Assets (A: Dec. 2021 )+Total Assets (A: Dec. 2022 ))/ count )
=-1.481/( (0.161+0.189)/ 2 )
=-1.481/0.175
=-846.29 %

PreveCeutical Medical's annualized ROA % for the quarter that ended in Sep. 2023 is calculated as:

ROA %=Net Income (Q: Sep. 2023 )/( (Total Assets (Q: Dec. 2022 )+Total Assets (Q: Sep. 2023 ))/ count )
=-0.96/( (0.189+0.209)/ 2 )
=-0.96/0.199
=-482.41 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

In the calculation of annual ROA %, the net income of the last fiscal year and the average total assets over the fiscal year are used. In calculating the quarterly data, the Net Income data used here is four times the quarterly (Sep. 2023) net income data. ROA % is displayed in the 30-year financial page.


PreveCeutical Medical  (XCNQ:PREV) ROA % Explanation

ROA % measures the rate of return on the total assets (shareholder equity plus liabilities). It measures a firm's efficiency at generating profits from shareholders' equity plus its liabilities. ROA % shows how well a company uses what it has to generate earnings. ROA %s can vary drastically across industries. Therefore, ROA % should not be used to compare companies in different industries. For retailers, a ROA % of higher than 5% is expected. For example, Wal-Mart (WMT) has a ROA % of about 8% as of 2012. For banks, ROA % is close to their interest spread. A bank’s ROA % is typically well under 2%.

Similar to ROE, ROA % is affected by profit margins and asset turnover. This can be seen from the Du Pont Formula:

ROA %(Q: Sep. 2023 )
=Net Income/Total Assets
=-0.96/0.199
=(Net Income / Revenue)*(Revenue / Total Assets)
=(-0.96 / 0)*(0 / 0.199)
=Net Margin %*Asset Turnover
=N/A %*0
=-482.41 %

Note: The Net Income data used here is four times the quarterly (Sep. 2023) net income data. The Revenue data used here is four times the quarterly (Sep. 2023) revenue data.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Be Aware

Like ROE, ROA % is calculated with only 12 months data. Fluctuations in the company's earnings or business cycles can affect the ratio drastically. It is important to look at the ratio from a long term perspective. ROA % can be affected by events such as stock buyback or issuance, and by goodwill, a company's tax rate and its interest payment. ROA % may not reflect the true earning power of the assets. A more accurate measurement is ROC % (ROC).

Many analysts argue the higher return the better. Buffett states that really high ROA % may indicate vulnerability in the durability of the competitive advantage.

E.g. Raising $43b to take on KO is impossible, but $1.7b to take on Moody's is. Although Moody's ROA % and underlying economics is far superior to Coca Cola, the durability is far weaker because of lower entry cost.


PreveCeutical Medical ROA % Related Terms

Thank you for viewing the detailed overview of PreveCeutical Medical's ROA % provided by GuruFocus.com. Please click on the following links to see related term pages.


PreveCeutical Medical (XCNQ:PREV) Business Description

Traded in Other Exchanges
Address
885 Cambie Street, Suite 2500, Vancouver, BC, CAN, V6B 0R6
PreveCeutical Medical Inc is a health sciences company. Its principal business activity is the development of innovative options for preventive and curative therapies utilizing organic and nature-identical products. It is engaged in licensing, branding, and marketing nutraceutical and wellness products.

PreveCeutical Medical (XCNQ:PREV) Headlines

No Headlines